Development and validation of bioanalytical method for the detection of gliclazide in human plasma
A robust High Performance Liquid Chromatography Diod Array Detection (HPLC- DAD) method was developed for the detection of gliclazide in human plasma. Liquid liquid extraction method was used as a sample preparation for HPLC analysis. The separation was carried out on Agilent Zorbax Reversed P...
Main Authors: | , , , |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/55423/ http://irep.iium.edu.my/55423/1/Development%20and%20Validation%20of%20Bioanalytical%20Method%20for%20the%20Detection.pdf |
id |
iium-55423 |
---|---|
recordtype |
eprints |
spelling |
iium-554232017-03-02T01:44:05Z http://irep.iium.edu.my/55423/ Development and validation of bioanalytical method for the detection of gliclazide in human plasma Alaama, Mohamed Helaluddin, Abul Bashar Mohammed Izat, I'zma Kamarbashrudin, Siti Khadijah Rose QD Chemistry R Medicine (General) RS Pharmacy and materia medica A robust High Performance Liquid Chromatography Diod Array Detection (HPLC- DAD) method was developed for the detection of gliclazide in human plasma. Liquid liquid extraction method was used as a sample preparation for HPLC analysis. The separation was carried out on Agilent Zorbax Reversed Phase C-18 column (150 x 4.6 mm, 5µ m) with PDA detection at 236 nm. with an isocratic elution (1 mL/min) at 30°C column temperature. The mobile phases used consisted of acetonitrile: 0.3% triethylamine buffer (pH=3.0 adjusted with H3PO4 85%) 57:43 v/v. Then, 10 µL aliquot samples were injected onto chromatographic system. The results showed that the retention time for the gliclazide and the internal standard, glibenclamide were 3.8 and 4.8 respectively. The method was linear over the range of 10 – 5000 ppb with R2 of 0.9971. The recoveries of the developed methods for gliclazide were found to be between 84.9% and 104.0%, while for the glibenclamide were found to be between 100.0% and 112.0%. The stability analysis showed that gliclazide is stable for at least 3 months but glibenclamide is degraded for about 2 months when stored at -20 ?. For conclusion, the develop method is suitable and reliable for the detection of gliclazide in human plasma. 2016 Conference or Workshop Item NonPeerReviewed application/pdf en http://irep.iium.edu.my/55423/1/Development%20and%20Validation%20of%20Bioanalytical%20Method%20for%20the%20Detection.pdf Alaama, Mohamed and Helaluddin, Abul Bashar Mohammed and Izat, I'zma and Kamarbashrudin, Siti Khadijah Rose (2016) Development and validation of bioanalytical method for the detection of gliclazide in human plasma. In: 2nd International Conference on Industrial Pharmacy (2nd ICIP 2016), 15th-16th Aug. 2016, Kuantan, Pahang. (Unpublished) |
repository_type |
Digital Repository |
institution_category |
Local University |
institution |
International Islamic University Malaysia |
building |
IIUM Repository |
collection |
Online Access |
language |
English |
topic |
QD Chemistry R Medicine (General) RS Pharmacy and materia medica |
spellingShingle |
QD Chemistry R Medicine (General) RS Pharmacy and materia medica Alaama, Mohamed Helaluddin, Abul Bashar Mohammed Izat, I'zma Kamarbashrudin, Siti Khadijah Rose Development and validation of bioanalytical method for the detection of gliclazide in human plasma |
description |
A robust High Performance Liquid Chromatography Diod Array Detection (HPLC- DAD) method
was developed for the detection of gliclazide in human plasma. Liquid liquid extraction method
was used as a sample preparation for HPLC analysis. The separation was carried out on Agilent
Zorbax Reversed Phase C-18 column (150 x 4.6 mm, 5µ m) with PDA detection at 236 nm. with
an isocratic elution (1 mL/min) at 30°C column temperature. The mobile phases used consisted
of acetonitrile: 0.3% triethylamine buffer (pH=3.0 adjusted with H3PO4 85%) 57:43 v/v. Then,
10 µL aliquot samples were injected onto chromatographic system. The results showed that the
retention time for the gliclazide and the internal standard, glibenclamide were 3.8 and 4.8
respectively. The method was linear over the range of 10 – 5000 ppb with R2 of 0.9971. The
recoveries of the developed methods for gliclazide were found to be between 84.9% and
104.0%, while for the glibenclamide were found to be between 100.0% and 112.0%. The
stability analysis showed that gliclazide is stable for at least 3 months but glibenclamide is
degraded for about 2 months when stored at -20 ?. For conclusion, the develop method is
suitable and reliable for the detection of gliclazide in human plasma. |
format |
Conference or Workshop Item |
author |
Alaama, Mohamed Helaluddin, Abul Bashar Mohammed Izat, I'zma Kamarbashrudin, Siti Khadijah Rose |
author_facet |
Alaama, Mohamed Helaluddin, Abul Bashar Mohammed Izat, I'zma Kamarbashrudin, Siti Khadijah Rose |
author_sort |
Alaama, Mohamed |
title |
Development and validation of bioanalytical method for the detection of gliclazide in human plasma |
title_short |
Development and validation of bioanalytical method for the detection of gliclazide in human plasma |
title_full |
Development and validation of bioanalytical method for the detection of gliclazide in human plasma |
title_fullStr |
Development and validation of bioanalytical method for the detection of gliclazide in human plasma |
title_full_unstemmed |
Development and validation of bioanalytical method for the detection of gliclazide in human plasma |
title_sort |
development and validation of bioanalytical method for the detection of gliclazide in human plasma |
publishDate |
2016 |
url |
http://irep.iium.edu.my/55423/ http://irep.iium.edu.my/55423/1/Development%20and%20Validation%20of%20Bioanalytical%20Method%20for%20the%20Detection.pdf |
first_indexed |
2023-09-18T21:18:20Z |
last_indexed |
2023-09-18T21:18:20Z |
_version_ |
1777411713531904000 |